Nuclivision, a Belgian medtech startup based in Ghent, has raised €5 million in funding from LUMO Labs, Heran Partners, and the imec.istart future fund. The investment will support the launch of Nuclivity's AI software platform, Nuclarity, aimed at enhancing medical imaging through PET scans. The platform reduces the dependency on costly and harmful radiotracers, thereby improving accessibility and safety in medical imaging processes. Founded in 2022, Nuclivision is focused on optimizing PET technology to aid in the early detection of conditions like cancer and Alzheimer's. The company is in the final phase of regulatory approval, with plans for expansion across Europe and the US.
Thu, 24 Apr 2025 06:22:35 GMT | Silicon Canals